479 related articles for article (PubMed ID: 30390802)
1. Hit-to-Lead: Hit Validation and Assessment.
Hevener KE; Pesavento R; Ren J; Lee H; Ratia K; Johnson ME
Methods Enzymol; 2018; 610():265-309. PubMed ID: 30390802
[TBL] [Abstract][Full Text] [Related]
2. A Guide to Run Affinity Screens Using Differential Scanning Fluorimetry and Surface Plasmon Resonance Assays.
Bergsdorf C; Wright SK
Methods Enzymol; 2018; 610():135-165. PubMed ID: 30390797
[TBL] [Abstract][Full Text] [Related]
3. Applications of Biophysics in High-Throughput Screening Hit Validation.
Genick CC; Barlier D; Monna D; Brunner R; Bé C; Scheufler C; Ottl J
J Biomol Screen; 2014 Jun; 19(5):707-14. PubMed ID: 24695619
[TBL] [Abstract][Full Text] [Related]
4. Hot-Spotting with Thermal Scanning: A Ligand- and Structure-Independent Assessment of Target Ligandability.
Chilton M; Clennell B; Edfeldt F; Geschwindner S
J Med Chem; 2017 Jun; 60(12):4923-4931. PubMed ID: 28537726
[TBL] [Abstract][Full Text] [Related]
5. Biophysics in drug discovery: impact, challenges and opportunities.
Renaud JP; Chung CW; Danielson UH; Egner U; Hennig M; Hubbard RE; Nar H
Nat Rev Drug Discov; 2016 Oct; 15(10):679-98. PubMed ID: 27516170
[TBL] [Abstract][Full Text] [Related]
6. Mass spectrometry for fragment screening.
Chan DS; Whitehouse AJ; Coyne AG; Abell C
Essays Biochem; 2017 Nov; 61(5):465-473. PubMed ID: 28986384
[TBL] [Abstract][Full Text] [Related]
7. Target immobilization as a strategy for NMR-based fragment screening: comparison of TINS, STD, and SPR for fragment hit identification.
Kobayashi M; Retra K; Figaroa F; Hollander JG; Ab E; Heetebrij RJ; Irth H; Siegal G
J Biomol Screen; 2010 Sep; 15(8):978-89. PubMed ID: 20817886
[TBL] [Abstract][Full Text] [Related]
8. Biophysical screening for the discovery of small-molecule ligands.
Ciulli A
Methods Mol Biol; 2013; 1008():357-88. PubMed ID: 23729259
[TBL] [Abstract][Full Text] [Related]
9. Affinity-based screening techniques: their impact and benefit to increase the number of high quality leads.
Bergsdorf C; Ottl J
Expert Opin Drug Discov; 2010 Nov; 5(11):1095-107. PubMed ID: 22827747
[TBL] [Abstract][Full Text] [Related]
10. Fragment-based lead discovery and design.
Joseph-McCarthy D; Campbell AJ; Kern G; Moustakas D
J Chem Inf Model; 2014 Mar; 54(3):693-704. PubMed ID: 24490951
[TBL] [Abstract][Full Text] [Related]
11. PAIN(S) relievers for medicinal chemists: how computational methods can assist in hit evaluation.
Stork C; Kirchmair J
Future Med Chem; 2018 Jul; 10(13):1533-1535. PubMed ID: 29956552
[No Abstract] [Full Text] [Related]
12. NMR-Fragment Based Virtual Screening: A Brief Overview.
Singh M; Tam B; Akabayov B
Molecules; 2018 Jan; 23(2):. PubMed ID: 29370102
[TBL] [Abstract][Full Text] [Related]
13. Fast and Efficient Fragment-Based Lead Generation by Fully Automated Processing and Analysis of Ligand-Observed NMR Binding Data.
Peng C; Frommlet A; Perez M; Cobas C; Blechschmidt A; Dominguez S; Lingel A
J Med Chem; 2016 Apr; 59(7):3303-10. PubMed ID: 26964888
[TBL] [Abstract][Full Text] [Related]
14. Experiences in fragment-based lead discovery.
Hubbard RE; Murray JB
Methods Enzymol; 2011; 493():509-31. PubMed ID: 21371604
[TBL] [Abstract][Full Text] [Related]
15. waveRAPID-A Robust Assay for High-Throughput Kinetic Screens with the Creoptix WAVEsystem.
Kartal Ö; Andres F; Lai MP; Nehme R; Cottier K
SLAS Discov; 2021 Sep; 26(8):995-1003. PubMed ID: 34049465
[TBL] [Abstract][Full Text] [Related]
16. From experimental design to validated hits a comprehensive walk-through of fragment lead identification using surface plasmon resonance.
Giannetti AM
Methods Enzymol; 2011; 493():169-218. PubMed ID: 21371592
[TBL] [Abstract][Full Text] [Related]
17. Fragment-Based Ligand Designing.
Katiyar SP; Malik V; Kumari A; Singh K; Sundar D
Methods Mol Biol; 2018; 1762():123-144. PubMed ID: 29594771
[TBL] [Abstract][Full Text] [Related]
18. One Question, Multiple Answers: Biochemical and Biophysical Screening Methods Retrieve Deviating Fragment Hit Lists.
Schiebel J; Radeva N; Köster H; Metz A; Krotzky T; Kuhnert M; Diederich WE; Heine A; Neumann L; Atmanene C; Roecklin D; Vivat-Hannah V; Renaud JP; Meinecke R; Schlinck N; Sitte A; Popp F; Zeeb M; Klebe G
ChemMedChem; 2015 Sep; 10(9):1511-21. PubMed ID: 26259992
[TBL] [Abstract][Full Text] [Related]
19. Biophysical methods in drug discovery from small molecule to pharmaceutical.
Holdgate G; Geschwindner S; Breeze A; Davies G; Colclough N; Temesi D; Ward L
Methods Mol Biol; 2013; 1008():327-55. PubMed ID: 23729258
[TBL] [Abstract][Full Text] [Related]
20. Fragments: where are we now?
Osborne J; Panova S; Rapti M; Urushima T; Jhoti H
Biochem Soc Trans; 2020 Feb; 48(1):271-280. PubMed ID: 31985743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
